Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults who are Hospitalized with Type A Influenza.

Trial Identifier:	D6000C00003
Sponsor:	MedImmune, LLC
NCTID::	NCT03028909
Start Date:	May 2017
Primary Completion Date:	May 2019
Study Completion Date:	May 2019
Condition:	Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.